These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8043237)

  • 41. Amoxycillin-clavulanic acid prescribing remains high in the elderly despite warnings of drug-associated jaundice.
    Parkes AJ
    Med J Aust; 1995 Oct; 163(8):446. PubMed ID: 7476624
    [No Abstract]   [Full Text] [Related]  

  • 42. Amoxicillin-potassium clavulanate: rational pharmacology meets clinical infectious disease.
    Reed MD; Blumer JL
    Clin Pharm; 1984; 3(6):653-4. PubMed ID: 6509880
    [No Abstract]   [Full Text] [Related]  

  • 43. [The pharmacokinetics, dosage, tolerance, side effects and safety of the preparation Augmentin (a combination of amoxicillin and clavulanic acid)].
    Robinson OP
    Antibiot Khimioter; 1992 Sep; 37(9):20-3. PubMed ID: 1444662
    [No Abstract]   [Full Text] [Related]  

  • 44. Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.
    Pien FD
    Antimicrob Agents Chemother; 1983 Dec; 24(6):856-9. PubMed ID: 6362559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical experience with intravenous Augmentin in the treatment of paediatric infections.
    Ploechl E; Huber EG
    J Int Med Res; 1986; 14(3):153-7. PubMed ID: 3636248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatitis caused by amoxicillin plus clavulanic acid].
    del Olmo ME; Panadero FJ; Palacios ML; Carreira J; Panadero E
    Aten Primaria; 1994 Jun; 14(1):579-80. PubMed ID: 7918969
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) in the fields of obstetrics and gynecology].
    Kishida H; Kisaka Y; Matsubayashi S; Hiraoka H; Naitoh H; Tanaka S; Urabe T; Fujiwara A
    Jpn J Antibiot; 1983 Mar; 36(3):487-99. PubMed ID: 6553605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.
    Feldman W; Sutcliffe T; Dulberg C
    CMAJ; 1990 Jan; 142(2):115-8. PubMed ID: 2403833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Miyachi Y; Ueda S; Hayakawa F; Nakashima T; Hakamada S; Kuno K
    Jpn J Antibiot; 1985 Feb; 38(2):423-30. PubMed ID: 4009951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of amoxycillin/clavulanate with amoxycillin in children and adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae.
    Jensen T; Pedersen SS; Stafanger G; Høiby N; Koch C; Bondesson G
    Scand J Infect Dis; 1988; 20(5):517-24. PubMed ID: 3065925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatment of lower respiratory tract infection. Lower Respiratory Tract Infection Collaborative Study Group.
    Calver AD; Walsh NS; Quinn PF; Baran C; Lonergan V; Singh KP; Orzolek WS
    Clin Infect Dis; 1997 Apr; 24(4):570-4. PubMed ID: 9145729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of respiratory tract infections in children: a study of a combination of amoxycillin and clavulanic acid.
    Fiocchi A; Zuccotti G; Bellù R; Marangione P; Riva E; Giovannini M
    J Int Med Res; 1990; 18(4):326-33. PubMed ID: 2227080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Augmentin hepatotoxicity: responsibility of clavulanic acid? Apropos of a case].
    Peroux JL; Peroux E; Jais F; Philit F; Chichmanian RM
    Gastroenterol Clin Biol; 1992; 16(1):102-3. PubMed ID: 1537473
    [No Abstract]   [Full Text] [Related]  

  • 55. Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion.
    Foshee WS
    J Pediatr; 1992 Jun; 120(6):980-6. PubMed ID: 1593361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cholestatic hepatitis from amoxicillin-clavulanic acid].
    Cabelleria Rovira E; Masso Ubeda RM; Arago López JV; Sanchís Closa A
    An Med Interna; 1992 Jul; 9(7):360-1. PubMed ID: 1633249
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination antibiotic for resistant bacterial strains.
    Pepper GA
    Nurse Pract; 1985 Mar; 10(3):49-50. PubMed ID: 3845395
    [No Abstract]   [Full Text] [Related]  

  • 58. A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.
    Rademaker CM; Sips AP; Beumer HM; Hoepelman IM; Overbeek BP; Möllers MJ; Rozenberg-Arska M; Verhoef J
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():75-81. PubMed ID: 2286595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium.
    Schneider JE; Kleinman MS; Kupiec JW
    N Y State J Med; 1989 Jun; 89(6):355-6. PubMed ID: 2739957
    [No Abstract]   [Full Text] [Related]  

  • 60. Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice.
    Tehan S; Lamb YJ
    J Antimicrob Chemother; 1990 Jul; 26(1):151-2. PubMed ID: 2211437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.